MHRA Class 4 Medicines Defect Information: Venlafaxine XL 150mg, 225mg, 300mg prolonged-release tablets (Macarthys Laboratories t/a Martindale Pharma)
Class 4 Medicines Defect Information: Venlafaxine XL 150mg, 225mg, 300mg prolonged-release tablets (Macarthys Laboratories t/a Martindale Pharma) Drug alert number: EL (23)A/10 Date issued: 16 March 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Venlafaxine XL 150mg prolonged-release tablets, PL01883/0340 SNOMED Code: 41468211000001100 Batch [...]
The post MHRA Class 4 Medicines Defect Information: Venlafaxine XL 150mg, 225mg, 300mg prolonged-release tablets (Macarthys Laboratories t/a Martindale Pharma) appeared first on PSNC Website.
Recent Comments